cIMPACT-NOW update 3: recommended diagnostic criteria for

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Brat DJ Department of Pathology, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Ward Building, 3-140, 303 E. Chicago Ave, Chicago, IL, 60611, USA. Daniel.brat@northwestern.edu.
Aldape K Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Colman H Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA.
Holland EC Department of Neurosurgery, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.
Louis DN Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Jenkins RB Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kleinschmidt-DeMasters BK Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
Perry A Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
Reifenberger G Department of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
Stupp R Malnati Brain Tumor Institute, Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
von Deimling A Department of Neuropathology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
Weller M Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.